Prakas Pharmacy Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 04-07-2024
- Paid Up Capital ₹ 1.00 M
as on 04-07-2024
- Company Age 12 Year, 1 Day
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.85 Cr
as on 04-07-2024
- Satisfied Charges ₹ 4.50 Cr
as on 04-07-2024
- Revenue 23.89%
(FY 2023)
- Profit -0.41%
(FY 2023)
- Ebitda 17.51%
(FY 2023)
- Net Worth 14.61%
(FY 2023)
- Total Assets 27.87%
(FY 2023)
About Prakas Pharmacy
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹4.85 Cr. The company has closed loans amounting to ₹4.50 Cr, as per Ministry of Corporate Affairs (MCA) records.
Mahalingam Sathish, Shanmathy, and Jayaseelan Pichamuthu serve as directors at the Company.
- CIN/LLPIN
U51397TN2012PTC089090
- Company No.
089090
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Dec 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Prakas Pharmacy?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mahalingam Sathish  | Additional Director | 01-Aug-2016 | Current |
| Shanmathy | Additional Director | 01-Aug-2016 | Current |
| Jayaseelan Pichamuthu | Additional Director | 01-Aug-2016 | Current |
Financial Performance of Prakas Pharmacy.
Prakas Pharmacy Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 23.89% increase. The company also saw a slight decrease in profitability, with a 0.41% decrease in profit. The company's net worth Soared by an impressive increase of 14.61%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Prakas Pharmacy?
In 2023, Prakas Pharmacy had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
R.S. Drugs And Medicals Private LimitedActive 7 years 8 monthsMahalingam Sathish and Jayaseelan Pichamuthu are mutual person
- Jandv Pharmacy Private LimitedActive 5 years 1 month
Shanmathy and Jayaseelan Pichamuthu are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 09 Apr 2018 | ₹4.85 Cr | Open |
Axis Bank Limited Creation Date: 22 Sep 2017 | ₹3.50 Cr | Satisfied |
Tamilnad Mercantile Bank Limited Creation Date: 11 Nov 2016 | ₹1.00 Cr | Satisfied |
How Many Employees Work at Prakas Pharmacy?
Unlock and access historical data on people associated with Prakas Pharmacy, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Prakas Pharmacy, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Prakas Pharmacy's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
